Fulton Breakefield Broenniman’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,579
Closed -$243K 190
2024
Q2
$243K Hold
23,579
0.02% 165
2024
Q1
$250K Hold
23,579
0.02% 161
2023
Q4
$215K Buy
+23,579
New +$215K 0.02% 168